These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 7980241

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fludarabine and acute tumor lysis in chronic lymphocytic leukemia.
    Frame JN, Dahut WL, Crowley S.
    N Engl J Med; 1992 Nov 05; 327(19):1396-7. PubMed ID: 1406856
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia.
    Cheson BD, Frame JN, Vena D, Quashu N, Sorensen JM.
    J Clin Oncol; 1998 Jul 05; 16(7):2313-20. PubMed ID: 9667245
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tumor lysis syndrome following chlorambucil therapy for chronic lymphocytic leukemia: case report and review of the literature.
    Kosseifi SG, Vyas B, Vyas H, Krishnaswamy G, Smith S.
    Tenn Med; 2009 Oct 05; 102(10):33-6. PubMed ID: 19899317
    [No Abstract] [Full Text] [Related]

  • 12. Lysis pneumonopathy associated with the use of fludarabine phosphate.
    Crowley JJ, Knight L, Charan N.
    West J Med; 1994 Dec 05; 161(6):597-9. PubMed ID: 7531920
    [No Abstract] [Full Text] [Related]

  • 13. Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia.
    Wierda WG, Byrd JC, O'Brien S, Coutre S, Barr PM, Furman RR, Kipps TJ, Burger JA, Stevens DA, Sharman J, Ghia P, Flinn IW, Zhou C, Ninomoto J, James DF, Tam CS.
    Br J Haematol; 2019 Jul 05; 186(1):184-188. PubMed ID: 30740654
    [No Abstract] [Full Text] [Related]

  • 14. Fludarabine induced immune thrombocytopenia in a patient with CD5 positive B cell chronic lymphocytic leukemia.
    Usman M, Adil SN, Sajid R, Khurshid M.
    J Pak Med Assoc; 2003 Oct 05; 53(10):496-7. PubMed ID: 14696895
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Probable autoimmune neutropenia induced by fludarabine treatment for chronic lymphocytic leukaemia.
    Stern SC, Shah S, Costello C.
    Br J Haematol; 1999 Sep 05; 106(3):836-7. PubMed ID: 10469479
    [No Abstract] [Full Text] [Related]

  • 19. Acute tumor lysis syndrome complicating fludarabine treatment of prolymphocytic leukemia.
    Cannon LM, Spilove L, Rhodes R, Garfinkel H, Pezzimenti J.
    Conn Med; 1993 Oct 05; 57(10):651-4. PubMed ID: 8275684
    [Abstract] [Full Text] [Related]

  • 20. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia.
    Bastion Y, Coiffier B, Dumontet C, Espinouse D, Bryon PA.
    Ann Oncol; 1992 Feb 05; 3(2):171-2. PubMed ID: 1606091
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.